← Leaderboards
Hannah Marion Burgess
New York University School Of Medicine
$583,659
Attributed
$583,659
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $381.4K · FY2021–22$500K$375K$250K$125K$0
'21
'22
Funding mix
By agency
NIH$583,659 · 2
By mechanism
R21$583,659 · 2
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Ian J. Mohr$18,844,159
- Angus Wilson$6,518,738
- Meagan P O'Brien$1,039,163
- Eva Hernando$15,270,218
- Joel G. Belasco$15,015,856
Others in their field
Other Emerging Leaders on “Pathogenicity”
- Scott Hensley · University Of Pennsylvania$49,758,212
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,703,204
- Thomas Denny · Duke University$42,477,454
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Sujatha Rashid · American Type Culture Collection$37,889,194
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
PathogenicityProtein BiosynthesisInnate Immune ResponsePathogenPhosphotransferasesPreventAntiviral ResponseInfectionMedicalMrna DecayPathway InteractionsPatternBindingPreservationDouble-Stranded RnaBiologyCellsHuman PathogenEndoribonucleasesCircular RnaMolecularMonitorAntiviral ImmunityProteins
Grant awards (6)
Cellular RNAs in anti-viral immunity to HSV1$135,000
R21 · FY2022 · AI · contact PI
Circular RNAs in HSV1 infection and antiviral immunity$67,284
R21 · FY2022 · AI · contact PI
Cellular RNAs in anti-viral immunity to HSV1 - Resubmission - 1$148,752
R21 · FY2021 · AI · contact PI
Cellular RNAs in anti-viral immunity to HSV1$105,498
R21 · FY2021 · AI · contact PI
Circular RNAs in HSV1 infection and antiviral immunity$74,837
R21 · FY2021 · AI · contact PI
Circular RNAs in HSV1 infection and antiviral immunity$52,288
R21 · FY2021 · AI · contact PI